Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells.

Shimizu Y, Shibata R, Shintani S, Ishii M, Murohara T.

J Am Heart Assoc. 2012 Aug;1(4):e000877. doi: 10.1161/JAHA.112.000877. Epub 2012 Aug 24.

2.

Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis.

Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M, Kitagawa Y, Murohara T.

Arterioscler Thromb Vasc Biol. 2009 Jan;29(1):61-6. doi: 10.1161/ATVBAHA.108.166496. Epub 2008 Oct 30.

3.

Multilayered adipose-derived regenerative cell sheets created by a novel magnetite tissue engineering method for myocardial infarction.

Ishii M, Shibata R, Shimizu Y, Yamamoto T, Kondo K, Inoue Y, Ouchi N, Tanigawa T, Kanemura N, Ito A, Honda H, Murohara T.

Int J Cardiol. 2014 Aug 20;175(3):545-53. doi: 10.1016/j.ijcard.2014.06.034. Epub 2014 Jul 2.

PMID:
25023793
4.

Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.

Hwang JH, Kim IG, Lee JY, Piao S, Lee DS, Lee TS, Ra JC, Lee JY.

Biomaterials. 2011 Jul;32(19):4415-23. doi: 10.1016/j.biomaterials.2011.02.051. Epub 2011 Mar 21.

PMID:
21421266
5.

Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.

Baker A, Kim H, Semple JL, Dumont D, Shoichet M, Tobbia D, Johnston M.

Breast Cancer Res. 2010;12(5):R70. doi: 10.1186/bcr2638. Epub 2010 Sep 8.

6.

Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.

Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, Kaneda Y.

Circulation. 2006 Sep 12;114(11):1177-84. Epub 2006 Sep 4.

7.

Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.

Kashiwagi S, Hosono K, Suzuki T, Takeda A, Uchinuma E, Majima M.

Lab Invest. 2011 Sep;91(9):1314-25. doi: 10.1038/labinvest.2011.84. Epub 2011 May 16.

8.

Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.

Kuwahara G, Nishinakamura H, Kojima D, Tashiro T, Kodama S.

J Vasc Surg. 2013 Apr;57(4):1090-9. doi: 10.1016/j.jvs.2012.08.121. Epub 2012 Dec 7.

9.

Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.

Kim IG, Lee JY, Lee DS, Kwon JY, Hwang JH.

J Vasc Res. 2013;50(2):124-33. doi: 10.1159/000343699. Epub 2012 Nov 27.

PMID:
23208012
10.

The resolution of lymphedema by interstitial flow in the mouse tail skin.

Uzarski J, Drelles MB, Gibbs SE, Ongstad EL, Goral JC, McKeown KK, Raehl AM, Roberts MA, Pytowski B, Smith MR, Goldman J.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1326-34. doi: 10.1152/ajpheart.00900.2007. Epub 2008 Jan 18.

11.

Adipose-derived regenerative cell (ADRC)-enriched fat grafting: optimal cell concentration and effects on grafted fat characteristics.

Kakudo N, Tanaka Y, Morimoto N, Ogawa T, Kushida S, Hara T, Kusumoto K.

J Transl Med. 2013 Oct 10;11:254. doi: 10.1186/1479-5876-11-254.

12.

An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis.

Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, An A, Rockson SG.

BioDrugs. 2006;20(6):363-70.

PMID:
17176124
13.

Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.

Yoshida S, Hamuy R, Hamada Y, Yoshimoto H, Hirano A, Akita S.

Regen Med. 2015;10(5):549-62. doi: 10.2217/rme.15.24.

PMID:
26237700
14.

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW.

J Clin Invest. 2003 Mar;111(5):717-25.

15.

[Experimental studies of VEGF-C gene for the treatment of chronic obstructive lymphedema in mouse tail model].

Hu XQ, Jiang ZH, Liu NF.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2008 May;24(3):207-11. Chinese.

PMID:
18717357
16.

Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention.

Zhu M, Zhou Z, Chen Y, Schreiber R, Ransom JT, Fraser JK, Hedrick MH, Pinkernell K, Kuo HC.

Ann Plast Surg. 2010 Feb;64(2):222-8. doi: 10.1097/SAP.0b013e31819ae05c.

PMID:
20098110
17.

Autologous adipose-derived regenerative cells for therapeutic angiogenesis.

Murohara T, Shintani S, Kondo K.

Curr Pharm Des. 2009;15(24):2784-90. Review.

PMID:
19689349
18.

Promotion of skeletal muscle repair in a rat skeletal muscle injury model by local injection of human adipose tissue-derived regenerative cells.

Mori R, Kamei N, Okawa S, Nakabayashi A, Yokota K, Higashi Y, Ochi M.

J Tissue Eng Regen Med. 2015 Oct;9(10):1150-60. doi: 10.1002/term.1659. Epub 2012 Dec 14.

PMID:
23239611
19.

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.

Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, Hamano K.

J Vasc Surg. 2010 Aug;52(2):429-34. doi: 10.1016/j.jvs.2010.03.017.

20.

Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema.

Zhou H, Wang M, Hou C, Jin X, Wu X.

Jpn J Clin Oncol. 2011 Jul;41(7):841-6. doi: 10.1093/jjco/hyr055. Epub 2011 May 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk